Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The association between antenatal corticosteroids exposure and postnatal growth in infants born between 23 and 29 weeks of gestation

Abstract

Objective

To assess the association between antenatal corticosteroids exposure and postnatal growth in infants born at 23–29 weeks’ gestation.

Study design

This retrospective study used data from the Pediatrix Clinical Data Warehouse. Maternal-infant dyads from 2018 to 2020 were included. Inverse propensity weighting (IPW) was applied to balance pre-treatment confounders. Primary outcomes included postnatal weight, length, and head circumference growth trajectory percentiles.

Result

The unadjusted cohort consisted of 11,912 dyads. After IPW adjustment, there were 23,231 dyads. Exposed infants showed higher postnatal trajectory percentiles for weight (by 3.4%), length (by 1.8%), and head circumference (by 2.5%) when compared to non-exposed infants. The positive association between antenatal corticosteroids and postnatal growth was only observed in infants not exposed to preeclampsia/eclampsia/HELLP syndrome or without fetal growth restriction.

Conclusion

Antenatal corticosteroids exposure is associated with better postnatal growth. The study is limited by its retrospective nature.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Study Cohort Breakdown.
Fig. 2: The impact of antenatal corticosteroids exposure on postnatal weight, length, and head circumference trajectory percentiles.

Similar content being viewed by others

Data availability

Data can be requested by contacting Dr. Reese Clark or by completing the online request form at https://mednax2ndhipaaaccount-gajdh.formstack.com/forms/research_application_complete.

References

  1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.

    PubMed  Google Scholar 

  2. Saito K, Nishimura E, Ota E, Namba F, Swa T, Ramson J, et al. Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review. BMJ Open. 2023;13:e065070.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Committee on obstetric practice. https://www.acog.org/-/media/project/acog/acogorg/clinical/files/committee-opinion/articles/2017/08/antenatal-corticosteroid-therapy-for-fetal-maturation.pdf (accessed 30 May 2023). (2017).

  4. Use of antenatal corticosteroids at 22 weeks of gestation. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/09/use-of-antenatal-corticosteroids-at-22-weeks-of-gestation (accessed 30 May 2023).

  5. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med. 1997;156:178–84.

    Article  CAS  PubMed  Google Scholar 

  6. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998;178:880–5.

    Article  CAS  PubMed  Google Scholar 

  7. Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birth weight and head circumference? Obstet Gynecol. 2002;99:101–8.

    CAS  PubMed  Google Scholar 

  8. Murphy KE, Willan AR, Hannah ME, Ohlsson A, Kelly EN, Matthews SG, et al. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol. 2012;119:917–23.

    Article  CAS  PubMed  Google Scholar 

  9. Rizzo G, Mappa I, Bitsadze V, Khizroeva J, Makatsariya A, D’Antonio F. Administration of antenatal corticosteroid is associated with reduced fetal growth velocity: a longitudinal study. J Matern Fetal Neonatal Med. 2022;35:2775–80.

    Article  CAS  PubMed  Google Scholar 

  10. Laptook AR, Weydig H, Brion LP, Wyckoff MH, Arnautovic TI, Younge N, et al. Antenatal steroids, prophylactic indomethacin, and the risk of spontaneous intestinal perforation. J Pediatr. 2023;259:113457.

    Article  CAS  PubMed  Google Scholar 

  11. Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019;25:1601–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hernán MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328:2446–7.

    Article  PubMed  Google Scholar 

  13. Hernández-Díaz S, Huybrechts KF, Chiu Y-H, Yland JJ, Bateman BT, Hernán MA. Emulating a target trial of interventions initiated during pregnancy with healthcare databases: the example of COVID-19 vaccination. Epidemiology. 2023;34:238–46.

    Article  PubMed  Google Scholar 

  14. Spitzer AR, Ellsbury DL, Handler D, Clark RH. The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system-tools for “meaningful use” in continuous quality improvement. Clin Perinatol. 2010;37:49–70.

    Article  PubMed  Google Scholar 

  15. Chou F-S, Yeh H-W, Clark RH. A comparative study of postnatal anthropometric growth in very preterm infants and intrauterine growth. Nat Commun. 2023;14:5626.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. twang: Toolkit for Weighting and Analysis of Nonequivalent Groups. Comprehensive R Archive Network (CRAN). https://cran.r-project.org/web/packages/twang/index.html (accessed 31 May 2023).

  17. Griffin BA, et al. Toolkit for Weighting and Analysis of Nonequivalent Groups (TWANG) Website. Santa Monica, CA: RAND Corporation, 2014. http://www.rand.org/statistics/twang.

  18. Survey: Analysis of Complex Survey Samples. Comprehensive R Archive Network (CRAN). https://cran.r-project.org/web/packages/survey/index.html (accessed 7 February 2023).

  19. Chou, F-S, Yeh, H-W, Clark RH Postnatal Growth Charts for Preterm Infants. https://nicugrowth.app (accessed 25 June 2023).

  20. Thorp JA, Jones PG, Peabody JL, Knox E, Clark RH. Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery. Obstet Gynecol. 2002;99:109–15.

    CAS  PubMed  Google Scholar 

  21. Chou F-S, Yeh H-W, Chen C-Y, Lee GT, Parrish MR, Omede M, et al. Exposure to placental insufficiency alters postnatal growth trajectory in extremely low birth weight infants. J Dev Orig Health Dis. 2020;11:384–91.

    Article  PubMed  Google Scholar 

  22. Chou F-S, Pandey V, Yeh H-W. Postnatal growth in extremely low birth weight newborns: nature or nurture? J Perinatol 2021;41:648–9.

    Article  PubMed  Google Scholar 

  23. Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther. 1988;3:158–64.

    Article  CAS  PubMed  Google Scholar 

  24. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab. 1993;77:1174–9.

    CAS  PubMed  Google Scholar 

  25. Ng PC. The fetal and neonatal hypothalamic-pituitary-adrenal axis. Arch Dis Child Fetal Neonatal Ed. 2000;82:F250–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

FC conceptualized the study, performed data analysis, and drafted the initial and revised manuscript. RHC performed initial data extraction and clean-up, and critically reviewed the manuscript. HY supervised data analysis and critically reviewed the manuscript.

Corresponding author

Correspondence to Fu-Sheng Chou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was determined by the Institutional Review Board of Kaiser Permanente Southern California to be non-human subject research due to the dataset’s de-identified nature, and the informed consent requirement was accordingly exempted.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chou, FS., Clark, R.H. & Yeh, HW. The association between antenatal corticosteroids exposure and postnatal growth in infants born between 23 and 29 weeks of gestation. J Perinatol 44, 561–567 (2024). https://doi.org/10.1038/s41372-024-01871-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-024-01871-0

Search

Quick links